Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al
Main Authors: | Campbell, P, Bareford, D, Erber, W, Wilkins, B, Wright, P, Buck, G, Wheatley, K, Harrison, C, Green, A |
---|---|
Format: | Journal article |
Published: |
2009
|
Similar Items
-
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
by: Wilkins, B, et al.
Published: (2008) -
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.
by: Campbell, P, et al.
Published: (2009) -
Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
by: Beer, P, et al.
Published: (2007) -
The medical research council PT1 trial in essential thrombocythemia.
by: Green, A, et al.
Published: (2004) -
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
by: Harrison, C, et al.
Published: (2005)